...
首页> 外文期刊>Clinical Rheumatology >Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils
【24h】

Anti-myeloperoxidase antibodies enhance phagocytosis, IL-8 production, and glucose uptake of polymorphonuclear neutrophils rather than anti-proteinase 3 antibodies leading to activation-induced cell death of the neutrophils

机译:抗髓过氧化物酶抗体可增强多形核中性粒细胞的吞噬作用,IL-8产生和葡萄糖摄取,而不是抗蛋白酶3抗体,从而导致中性粒细胞活化诱导的细胞死亡

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Anti-neutrophil cytoplasmic antibodies (ANCA) not only are triggered by target protein myeloperoxidase (MPO) and proteinase 3 (PR3) of polymorphonuclear neutrophil (PMN) but also react with primed PMN to exert the inflammatory process in vasculitis syndrome. To clarify the crucial role of PMN in ANCA-associated vasculitis and the related mechanism, PMN was cultured with monoclonal antibody MPO–ANCA and PR3–ANCA to determine the function of phagocytosis, Interleukin- 8 (IL-8) production, glucose uptake, and TNF-related apoptosis induced ligand (TRAIL) production. The spontaneous membrane expression of MPO and PR3 on PMN could be significantly increased by lipopolysaccharide (LPS) and TNF-α, but not by IL-8 or GRO-α. The PMN-stimulating activity of ANCA was demonstrated by enhancing phagocytosis, IL-8 production, and glucose uptake that was more prominent by MPO–ANCA. The PMN stimulation by ANCA was not through protein kinase, H2O2, or superoxide anion radicals as their inhibitors exerted no effect on ANCA-mediated activation. On the other hand, ANCA also accelerated PMN apoptosis and increased TRAIL production. These results demonstrate that activation-induced cell death (AICD) mechanism could be initiated in PMN with existence of ANCA. In conclusion, MPO–ANCA is more potent in stimulating PMN than PR3–ANCA. ANCA-activated PMN is not only responsible for the amplified inflammatory process in blood vessel but also initiates immune circuit via triggered macrophage/monocyte by apoptotic PMN through the mechanism of AICD elicited by ANCA.
机译:抗中性粒细胞胞浆抗体(ANCA)不仅由多形核中性粒细胞(PMN)的靶蛋白髓过氧化物酶(MPO)和蛋白酶3(PR3)触发,而且还与引发的PMN反应,在血管炎综合征中发挥炎症作用。为了阐明PMN在与ANCA相关的血管炎中的关键作用及其相关机制,将PMN与单克隆抗体MPO–ANCA和PR3–ANCA培养,以确定吞噬功能,白介素8(IL-8)产生,葡萄糖摄取,与TNF相关的凋亡诱导配体(TRAIL)的产生。脂多糖(LPS)和TNF-α可显着增加PMN上MPO和PR3的自发膜表达,而IL-8或GRO-α则不会。通过增强吞噬作用,IL-8的产生和葡萄糖的摄取证明了ANCA的PMN刺激活性,MPO-ANCA更为突出。 ANCA对PMN的刺激不是通过蛋白激酶,H2 O2 或超氧阴离子自由基进行的,因为它们的抑制剂对ANCA介导的活化没有作用。另一方面,ANCA还促进PMN凋亡并增加TRAIL的产生。这些结果表明激活诱导的细胞死亡(AICD)机制可以在ANCA存在的情况下在PMN中引发。总之,MPO–ANCA比PR3–ANCA更有效地刺激PMN。 ANCA激活的PMN不仅负责血管中的炎症过程的放大,而且还通过ANCA引发的AICD的机制,通过凋亡的PMN通过触发的巨噬细胞/单核细胞启动免疫回路。

著录项

  • 来源
    《Clinical Rheumatology》 |2007年第2期|216-224|共9页
  • 作者单位

    Department of Internal Medicine National Taiwan University Hospital National Taiwan University College of Medicine 7 Chung-Shan South Road Taipei Taiwan;

    Department of Dermatology National Taiwan University Hospital National Taiwan University College of Medicine Taipei Taiwan;

    Department of Laboratory Medicine Taipei Municipal Jen-Ai Hospital Taipei Taiwan;

    Department of Internal Medicine Buddish Xindian-Tzu-Chi General Hospital Taipei Taiwan;

    Department of Internal Medicine Buddish Xindian-Tzu-Chi General Hospital Taipei Taiwan;

    Department of Internal Medicine National Taiwan University Hospital National Taiwan University College of Medicine 7 Chung-Shan South Road Taipei Taiwan;

    Section of Allergy Immunology and Rheumatology Veterans General Hospital Taipei Taiwan;

    Department of Internal Medicine National Taiwan University Hospital National Taiwan University College of Medicine 7 Chung-Shan South Road Taipei Taiwan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Activation-induced cell death; Anti-neutrophil cytoplasmic autoantibody; Myeloperoxidase; Polymorphonuclear neutrophil; Proteinase-3;

    机译:活化诱导的细胞死亡;抗中性粒细胞胞浆自身抗体;髓过氧化物酶;多形核中性粒细胞;蛋白酶3;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号